YTHDF2 and hepatocellular carcinoma: Regarding the molecular mechanism, METTL3 increased the m6A level in SOCS2 mRNA, promoted the degradation of SOCS2 mRNA through an m6A-YTHDF2-dependent mechanism, and inhibited the expression of SOCS2 in HCC tissues, thus promoting HCC progression [105].